| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Albemarle Corp CMN | 57,328 | 54,048 |
| Pfizer, Inc. | 75,990 | 96,840 |
| Occidental Petroleum Corp | 60,488 | 47,852 |
| California Resources Corp | 2,184 | 652 |
| Ziopharm Oncology Inc | 24,905 | 83,100 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Zazove | 43,000 | ||
| Xanthus | 218,809 | 246,112 |
| Description | Amount |
|---|---|
| Posting error - prior year | 11 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| Xanthus K-1 pass thru income | 5,421 | 5,421 | |
| Refund of advisory fees | 1,357 | 1,357 | |
| Miscellaneous Income | 201 | 201 |
| Description | Amount |
|---|---|
| Net short term capital gain | 31 |
| Net long term capital gain | 68,027 |
| Capital gains sale of investments | 19,293 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| Federal Taxes Payable | ||
| Federal Taxes Payable |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| Federal Taxes Payable | ||
| Federal Taxes Payable |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Federal Taxes | 1,942 | 1,942 | ||
| Xanthus K-1 pass thru invst int | 2,053 | 2,053 |